Floatz logo

Therapeutic Asset Ratings

3,229 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Letrozole
Vitamin D Deficiency
Umm Al-Qura UniversityP4BB (67)
Leuporelin
Prostate Cancer
Mayo ClinicP4BB (67)
Lidocaine
Breast Cancer
Instituto Nacional de Cancer, BrazilP4BB (67)
Lidocaine
Stroke Disorder
Institut National de la Santé Et de la Recherche Médicale, FranceP4BB (67)
Linvoseltamab
Plasma Cell Myeloma
Anne Louise Tølbøll SørensenP4BB (67)
Lithium, Elemental
Dementia
University of ChileP4BB (67)
Marcaine
Postherpetic Neuralgia
Shirong TanP4BB (67)
Melphalan
B-Cell Non-Hodgkin Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (67)
Melphalan
Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (67)
Melphalan
Plasma Cell Myeloma
Dana-Farber Cancer InstituteP4BB (67)
Melphalan
Primary Mediastinal Large B-Cell Lymphoma
Fred Hutchinson Cancer CenterP4BB (67)
Memantine Hydrochloride
Alzheimer Disease
Bigespas LTDP4BB (67)
Metformin
Hyperinsulinism
Attikon HospitalP4BB (67)
Metoclopramide
Aspiration Pneumonia
Mater Misericordiae University HospitalP4BB (67)
Midazolam
Bipolar Disorder
Joshua RosenblatP4BB (67)
Mitoxantrone
Acute Lymphoblastic Leukemia
Tanja Andrea GruberP4BB (67)
Mitoxantrone
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP4BB (67)
Moviprep
Colorectal Cancer
Radboud University Medical CenterP4BB (67)
Nicardipine
Hypertensive Disorder
Universitas Sumatera UtaraP4BB (67)
Nivestim
Acute Myeloid Leukemia
City of Hope Medical CenterP4BB (67)
Nivestim
Breast Cancer
MedSIRP4BB (67)
Normal Human Serum Albumin
Urinary System Neoplasm
Region SkaneP4BB (67)
Olaparib
Renal Cell Carcinoma
Oliver JonasP4BB (67)
OTL-38
Ovarian Cancer
On Target Laboratories, LLCP4BB (67)
Pancrelipase
Chronic Pancreatitis
Changhai HospitalP4BB (67)
Showing 1451 to 1475 of 3,229 assets
PreviousPage 59 of 130Next